On May 14th, SBP GROUP (01177) spent 10.0364 million Hong Kong dollars to repurchase 1,820,000 shares.
China Biopharmaceuticals (01177) announced that the company repurchased 1.82 million shares on May 14, 2026, at a cost of 10.0364 million Hong Kong dollars, with a repurchase price of 5.51-5.52 Hong Kong dollars per share.
SBP GROUP (01177) announced that the company will repurchase 1.82 million shares at a total cost of 10.0364 million Hong Kong dollars on May 14, 2026. The repurchase price per share is between 5.51 and 5.52 Hong Kong dollars.
Related Articles
On May 14th, DEEWIN (02418) spent approximately 3.3612 million Hong Kong dollars to buy back 900,000 shares.
MADISON HLDG(08057): The share consolidation will take effect from May 18th.
Eastroc Beverage(09980): Chengdu base signed the "State-owned construction land use right transfer contract" with the Planning and Natural Resources Bureau of Wenjiang District, Chengdu City.
On May 14th, DEEWIN (02418) spent approximately 3.3612 million Hong Kong dollars to buy back 900,000 shares.
MADISON HLDG(08057): The share consolidation will take effect from May 18th.
Eastroc Beverage(09980): Chengdu base signed the "State-owned construction land use right transfer contract" with the Planning and Natural Resources Bureau of Wenjiang District, Chengdu City.
RECOMMEND
Two Mainland Accounting Firms Approved for H‑Share Audits, Lowering Listing Costs and Deepening Mainland–Hong Kong Market Integration**The Ministry of Finance, the CSRC, and Hong Kong’s Accounting and Financial Reporting Council have approved two additional mainland accounting firms—RSM China and ShineWing—to conduct H‑share audit work, marking the first expansion of the list since 2010.
11/05/2026
HKEX Tightens Rules on Auditor Dismissals as Sudden “Audit Firm Switches” Raise Governance Concerns
11/05/2026
The Chip Stock Frenzy Is Still Accelerating
11/05/2026
